To test whether pharmacological inhibition of GFPT1 and OGT inhibits cellular proliferation, we treated CRC cells with azaserine, a GFPT1 inhibitor, and OSMI-1, an OGT inhibitor. The gene discussed is OGT; the disease is colorectal carcinoma.